Taste Test of a New Formulation of Sildenafil (Revatio)
- Registration Number
- NCT00768573
- Lead Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Brief Summary
taste of formulation
- Detailed Description
taste test None
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 4
Inclusion Criteria
- Healthy
Exclusion Criteria
- History of hypersensitivity to test compounds or excipients.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 1. Taste test sildenafil -
- Primary Outcome Measures
Name Time Method palatability (aroma, flavour texture and mouth feel) Duration of study.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms of sildenafil in oral suspension formulations affect palatability in NCT00768573?
How does sildenafil's oral suspension compare to standard formulations in terms of bioavailability and taste perception?
Are there specific biomarkers that correlate with improved palatability of sildenafil in clinical trials?
What adverse events are associated with sildenafil oral suspension formulations in healthy volunteers?
How do formulation changes in sildenafil impact patient adherence and therapeutic outcomes in pulmonary arterial hypertension?
Trial Locations
- Locations (1)
Pfizer Investigational Site
🇺🇸Cambridge, Massachusetts, United States
Pfizer Investigational Site🇺🇸Cambridge, Massachusetts, United States